UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Abstract P6-09-11: Ki67 cut offs and oncotype DX recurrence score in early breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-09-11

2018

Volltextzugriff (PDF)

Abstract P1-06-12: Optimizing the use of oncotype Dx in early breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-06-12

2018

Volltextzugriff (PDF)

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Journal of clinical oncology, 2016-10, Vol.34 (28), p.3400-3408

2016

Volltextzugriff (PDF)

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

Annals of oncology, 2014-03, Vol.25 (3), p.592-598

2014

Volltextzugriff (PDF)

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

Clinical breast cancer, 2017-12, Vol.17 (8), p.585-594.e4

2017

Volltextzugriff (PDF)

Abstract P1-07-18: Breast cancer in young patients, twelve years of experience in a single institution

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-07-18

2016

Volltextzugriff (PDF)

Abstract P5-09-08: Molecular evaluation of Peruvian patients with hereditary breast cancer reveals a novel germline mutation in BRCA1

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-09-08

2017

Volltextzugriff (PDF)

Abstract P5-18-01: Extended continuous vs intermittent adjuvant letrozole in postmenopausal women with lymph node-positive, early breast cancer (IBCSG 37-05/BIG 1-07 SOLE): Impact on patient-reported symptoms and quality of life

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-18-01

2018

Volltextzugriff (PDF)

Abstract GS4-02: Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor positive (HR+) early breast cancer (BC): Update of the combined TEXT and SOFT trials

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS4-02-GS4-02

2018

Volltextzugriff (PDF)

Abstract P5-23-02: Quality of life (QoL) in male breast cancer (BC): Prospective study of the EORTC10085/TBCRC029/BIG2-07/NABCG International male BC program

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-23-02

2018

Volltextzugriff (PDF)

Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS4-07-GS4-07

2019

Volltextzugriff (PDF)

Abstract P1-15-01: Final analysis of SWOG S0230/Prevention of early menopause study (POEMS)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-15-01

2018

Volltextzugriff (PDF)

Abstract OT1-02-01: Pilot study of prognostic utility of circulating tumor cells (CTCs) assessed by AdnaGen technology and clinical outcome of patients with stage III breast cancer who completed locoregional and systemic treatment

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-02-01-OT1-02-01

2016

Volltextzugriff (PDF)

A Phase II Trial of Pemetrexed in Advanced Breast Cancer: Clinical Response and Association with Molecular Target Expression

Clinical cancer research, 2006-02, Vol.12 (3), p.832-838

2006

Volltextzugriff (PDF)

Abstract P6-07-21: Signs and symptoms at central nervous system (CNS) relapse in breast cancer patients with Leptomeningeal carcinomatosis related with shorter survival after recurrence

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-07-21

2012

Volltextzugriff (PDF)

P3-05-06: Progression of Breast Cancer Molecular Subtypes through Different Clinical Stages

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-05-06

2011

Volltextzugriff (PDF)

P2-14-09: Comparison between Spanish and Peruvian Patients with Early Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-14-09

2011

Volltextzugriff (PDF)

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value

Breast cancer research : BCR, 2011-11, Vol.13 (Suppl 2), p.P6-P6, Article P6

2011

Volltextzugriff (PDF)

Lapatinib is active in patients with HER2-amplified breast tumors expressing p95HER2

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.708

2009

Volltextzugriff (PDF)

Iron needles in supernova remnants?

Monthly notices of the Royal Astronomical Society, 2005-08, Vol.361 (3), p.1012-1014

2005

Volltextzugriff (PDF)

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-08-01

2016

Volltextzugriff (PDF)

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS2-04-GS2-04

2019

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(37)
Humans
(26)
Adult
(18)
Male
(18)
Female
(15)
Biological And Medical Sciences
(12)
Middle Aged
(12)
Aged
(11)
Technology
(9)
Medical Sciences
(8)
Medicin Och Hälsovetenskap
(8)
Oncology
(8)
Social Sciences
(7)
Computer Science
(6)
Computer Science, Artificial Intelligence
(6)
Management
(6)
Physical Sciences
(6)
Adolescent
(5)
Business
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract P6-09-11: Ki67 cut offs and oncotype DX recurrence score in early breast cancer

Abstract P1-06-12: Optimizing the use of oncotype Dx in early breast cancer

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

Abstract P1-07-18: Breast cancer in young patients, twelve years of experience in a single institution

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

Abstract P5-09-08: Molecular evaluation of Peruvian patients with hereditary breast cancer reveals a novel germline mutation in BRCA1

Abstract P5-18-01: Extended continuous vs intermittent adjuvant letrozole in postmenopausal women with lymph node-positive, early breast cancer (IBCSG 37-05/BIG 1-07 SOLE): Impact on patient-reported symptoms and quality of life

Abstract GS4-02: Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor positive (HR+) early breast cancer (BC): Update of the combined TEXT and SOFT trials

Abstract P5-23-02: Quality of life (QoL) in male breast cancer (BC): Prospective study of the EORTC10085/TBCRC029/BIG2-07/NABCG International male BC program

Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial

Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study

Abstract P1-15-01: Final analysis of SWOG S0230/Prevention of early menopause study (POEMS)

Abstract OT1-02-01: Pilot study of prognostic utility of circulating tumor cells (CTCs) assessed by AdnaGen technology and clinical outcome of patients with stage III breast cancer who completed locoregional and systemic treatment

A Phase II Trial of Pemetrexed in Advanced Breast Cancer: Clinical Response and Association with Molecular Target Expression

Abstract P6-07-21: Signs and symptoms at central nervous system (CNS) relapse in breast cancer patients with Leptomeningeal carcinomatosis related with shorter survival after recurrence

P3-05-06: Progression of Breast Cancer Molecular Subtypes through Different Clinical Stages

P2-14-09: Comparison between Spanish and Peruvian Patients with Early Breast Cancer

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value

Lapatinib is active in patients with HER2-amplified breast tumors expressing p95HER2

Iron needles in supernova remnants?

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

Suchergebnisse filtern